Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$7.52−0.27 (-3.47%)

Close on Nov 13, 2026Market cap $102.61MP/E –Yield 0.00%

Immunic statistics

65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $102.61M; $272.32M
Enterprise Value: -$29.36M; $146.23M
PB Ratio: 0.98; 2.00
P/TBV Ratio: 0.98; 2.22

Share statisticsIndustry

Shares Outstanding: 14M; 58M
Shares Change (YoY): 155.4%; 10.8%
Shares Change (QoQ): -11.8%; 0.50%
Shares Held by Institutions: 63.7%; 56.4%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: 4.75%; -0.80%
Short % of Shares Outstanding: 14.3%; 6.30%
Days to Cover: 5.73; 5.15

Stock price statisticsIndustry

52-Week High: $17.43; –
52-Week Low: $5.06; –
20-Day Moving Average: $7.60; –
50-Day Moving Average: $8.70; –
200-Day Moving Average: $11.56; –
Average True Range (14): $0.59; –
Price Change (1 Week): -2.97%; -1.15%
Price Change (1 Month): 5.92%; -4.87%
Price Change (3 Months): -53.1%; -21.0%
Price Change (6 Months): -37.7%; -20.6%
Price Change (YTD): 40.9%; -23.6%
Price Change (1 Year): -1.04%; -22.4%
Price Change (3 Years): -24.1%; -29.5%
Price Change (5 Years): -92.2%; -77.9%
Price Change (10 Years): -99.7%; -65.4%
Average Volume (10 Days): 200,294; –
Average Volume (20 Days): 270,860; –
Average Volume (90 Days): 288,667; –
Relative Volume: 0.37; 0.70
Relative Strength Index (14): 43.5; 43.4
Volatility (1 Year): 81.9%; 80.1%
Beta (5 Years): 1.03; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -223.2%; -49.9%
Return on Assets (ROA): -144.9%; -40.6%
Return on Capital Employed (ROCE): -129.0%; -37.9%

Financial positionIndustry

Current Ratio: 4.28; 3.30
Quick Ratio: 4.18; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.39M; -$689.41K
Employee Count: 92; 74
WACC: 10.2%; 10.2%

Income statement (TTM)Industry

Operating Income: -$135.26M; -$21.37M
Net Income: -$128.30M; -$22.35M
EBITDA: -$135.11M; -$17.21M
EPS (Diluted): -$3.86; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $131.96M; $68.68M
Net Cash (Debt): $131.96M; $17.76M
Net Cash Per Share: $9.67; $0.80
Equity (Book Value): $104.47M; $53.89M
Book Value Per Share: $7.66; $1.50
Tangible Book Value: $104.47M; $27.13M
Working Capital: $103.54M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$95.97M; -$12.38M
Capital Expenditures: -$366.00K; -$1.00M
Free Cash Flow: -$96.34M; -$18.21M
FCF Per Share: -$7.06; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -125.0%; -21.8%
FCF Yield: -93.9%; -9.44%
Dividend Yield: 0.00%; 1.88%
Shareholder Yield: 0.00%; 0.00%
Dividend Per Share: $0.00; $0.83
Years of Dividend Growth: 0; 0

Scores and fair valueIndustry

Altman Z-Score: -7.80; 0.23
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	IMUX	S&P 500	Difference	IMUX per year	S&P 500 per year
1 month	+9.1%	-3.0%	+12.2 pts
3 months	-54.6%	-2.8%	−51.9 pts
Year to date	+40.9%	+11.5%	+29.4 pts
1 year	+5.5%	+13.5%	−7.9 pts
3 years	-22.4%	+77.7%	−100.1 pts	-8.1%	+21.1%
5 years	-92.2%	+72.6%	−164.9 pts	-40.0%	+11.5%
10 years	-99.7%	+308.2%	−407.9 pts	-44.0%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M IMUX shares were sold short on Oct 30, 2026, up 4.8% from the previous report. At recent volumes it would take 5.7 days to buy them back. Over the last 20 sessions, 50.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,950,146	+4.8%	340,571	5.7
Oct 15, 2026	1,861,639	-10.3%	454,131	4.1
Sep 30, 2026	2,075,709	+15.7%	455,370	4.6
Sep 15, 2026	1,794,772	+20.4%	356,386	5.0
Aug 31, 2026	1,490,847	+16.7%	194,796	7.7
Aug 14, 2026	1,277,166	-10.9%	182,161	7.0
Jul 31, 2026	1,433,665	+1.4%	141,495	10.1
Jul 15, 2026	1,413,871	-10.9%	149,504	9.5
Jun 30, 2026	1,587,111	-2.7%	211,003	7.5
Jun 15, 2026	1,630,369	-7.6%	223,425	7.3
May 29, 2026	1,764,788	+12.7%	266,625	6.6
May 15, 2026	1,566,308	+17.2%	273,036	5.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?